Abstract
Liquid biopsies are revolutionizing the fields of prenatal non-invasive testing and cancer diagnosis by leveraging the genetic differences between mother and fetus, and, host and cancer. In the absence of genetic variance, epigenetics has been used to decipher the cell-of-origin of cell-free DNA (cfDNA). Liquid biopsies are minimally invasive and thus represent an attractive option for hard to biopsy tissues such as the brain. Here we report the first evidence of neuron derived cfDNA and cerebellum cfDNA within acute neurotrauma and chronic neurodegeneration, establishing the first class of peripheral biomarkers with specificity for the cell-type and brain-region undergoing potential injury and/or neurodegeneration.
ABBREVIATIONS
- (cfDNA)
- Cell-Free DNA
- (DLPFC)
- Dorsolateral Prefrontal Cortex
- (HM450)
- Illumina Infinium Human Methylation Microarray 450K platform
- (WGBS)
- Whole Genome Bisulfite Sequencing
- (DMR)
- Differentially Methylated Region
- (DMP)
- Differentially Methylated Positions
- (tNGBS)
- Targeted Next Generation Bisulfite Sequencing
- (TBI)
- Traumatic Brain Injury
- (PD)
- Parkinson’s Disease
- (CDR)
- Clinical Dementia Rating
- (NGS)
- Next Generation Sequencing
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.